Radiochemistry, pre-clinical studies and first clinical investigation of 90 Y-labeled hydroxyapatite (HA) particles prepared utilizing 90 Y produced by (n,γ) route
K.V. Vimalnath(Bhabha Atomic Research Centre), Ashutosh Dash(Bhabha Atomic Research Centre), Sudipta Chakraborty, J. Nuwad(Bhabha Atomic Research Centre), Usha Pandey(Bhabha Atomic Research Centre), A. Rajeswari(Bhabha Atomic Research Centre), Koramadai Karuppusamy Kamaleshwaran(Kovai Medical Center and Hospital), Ajit Shinto(Kovai Medical Center and Hospital), Haladhar Dev Sarma(Bhabha Atomic Research Centre)
Cited by 25
Related Papers
Production of 177Lu for Targeted Radionuclide Therapy: Available Options
|Nuclear Medicine and Molecular Imaging|2015|375
Sustained Availability of <sup>99m</sup>Tc: Possible Paths Forward
|Journal of Nuclear Medicine|2012|140
Peptide Receptor Radionuclide Therapy: An Overview
|Cancer Biotherapy and Radiopharmaceuticals|2015|122
Targeted Radionuclide Therapy - An Overview
|Current Radiopharmaceuticals|2013|117
Development of an electrochemical 90Sr–90Y generator for separation of 90Y suitable for targeted therapy
|Nuclear Medicine and Biology|2008|99